Home Markets Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lilly-nears-13-billion-deal-for-geneediting-biotech-verve-therapeutics-ft-reports-4098210

You May Also Like

Trump disclosures show $51M+ invested in bonds in March

Buy these memory stocks to play the red-hot CPU trade: Analyst

Brands and Retailers: What is the state of the marketing landscape

Exclusive-US State Dept orders global warning about alleged China AI thefts by DeepSeek, others

US considers using Defense Production Act in Spirit Airlines restructuring, source says

CFTC sues New York to block oversight of prediction markets